Department of Internal Medicine, University of Connecticut Medical Center, Farmington, CT, USA.
Pancreas. 2012 Aug;41(6):827-34. doi: 10.1097/MPA.0b013e31824c1598.
Acute pancreatitis (AP) is a common inflammatory disorder of the pancreas resulting in considerable morbidity and mortality. Aggressive intravenous fluid resuscitation generally is recommended in all patients with AP and remains the cornerstone of management of these patients. However, the optimal rate, type, and the goal of resuscitation remain unclear. The purpose of this review was to give an insight about the pathophysiologic alterations in the pancreatic microcirculation that occur in AP, the markers for early recognition of severity of pancreatitis, the optimal fluid, and timing and extent of fluid resuscitation. An early elevated hematocrit, blood urea nitrogen, or creatinine should prompt clinicians to institute more intensive early resuscitation measures. Crystalloids are the currently recommended fluids for management of these patients. Current studies are underway to determine the optimal end points of fluid resuscitation that determine outcome.
急性胰腺炎(AP)是一种常见的胰腺炎症性疾病,可导致相当高的发病率和死亡率。一般建议对所有 AP 患者进行积极的静脉补液复苏,这仍然是这些患者治疗的基石。然而,最佳的复苏速率、类型和目标仍不清楚。本综述的目的是深入了解 AP 中发生的胰腺微循环病理生理改变、胰腺炎严重程度的早期识别标志物、最佳液体以及液体复苏的时机和程度。早期升高的红细胞压积、血尿素氮或肌酐应促使临床医生采取更积极的早期复苏措施。晶体液是目前推荐用于此类患者治疗的液体。目前正在进行研究,以确定决定预后的液体复苏的最佳终点。